Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Gevo, Inc.GEVO · Entity 5641 | Chief Accounting Officer | August 09, 2018 | August 13, 2018 |
| SeaStar Medical Holding CorpICU · Entity 7863 | Principal Accounting Officer | February 06, 2026 | February 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Gevo, Inc.
Report date August 09, 2018 · Filed August 13, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2018-08-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-09 · Grant · Acquired 30,000 · Balance 30,000 F1: Represents restricted common stock that vests 100% on August 9, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted common stock that vests 100% on August 9, 2019.
SeaStar Medical Holding Corp
Report date February 06, 2026 · Filed February 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 9,050 |
Reported balance
After 2026-02-06 transaction · row 1
1 source rowRow 1 · 2026-02-06 · Grant · Acquired 7,500 · Balance 9,050 F1: Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2026 Filed Feb 10, 2026 21:56 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003670 · rdgdoc.xml · nonDerivative · entry 1 Towne Bradford K · CIK 0001728197 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,050 F1 · shares: Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026 Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:24 UTC | Gevo, Inc. GEVO · Entity 5641 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046427 · doc4.xml · nonDerivative · entry 1 Towne Bradford K · CIK 0001728197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · security: Represents restricted common stock that vests 100% on August 9, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.